Akebia Therapeutics Signs Commercial Supply Contract ...

Press Release · Akebia Therapeutics Signs Commercial Supply Contract with Leading Dialysis Organization to Enable Access to Vafseo® (vadadustat) for Patients on ...

Akebia Therapeutics and U.S. Renal Care Sign Commercial Supply ...

Press Release · Akebia Therapeutics and U.S. Renal Care Sign Commercial Supply Contract to Enable Access to Vafseo® (vadadustat) for Patients on Dialysis.

Akebia Therapeutics Signs Commercial Supply Contract with ...

Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney ...

Akebia Therapeutics, US Renal Care enter deal to offer Vafseo to ...

Akebia Therapeutics and U.S. Renal Care sign commercial supply contract to enable access to Vafseo (vadadustat) for patients on dialysis. https ...

Akebia Therapeutics Signs Commercial Supply Contract with ...

Akebia Therapeutics secures major contract, expanding access to FDA-approved Vafseo for 200000+ dialysis patients.

Akebia Therapeutics (AKBA) Signs Commercial Supply Contract ...

Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, ...

FORM 8-K - Akebia Therapeutics

(the “Company”) issued a press release announcing that it signed a mult-year commercial supply ... Signs Commercial Supply Contract with Leading Dialysis ...

Akebia Therapeutics and U.S. Renal Care sign commercial supply ...

Akebia Therapeutics and US Renal Care (USRC) have recently announced entry into a multi-year commercial supply contract encompassing all USRC dialysis centres.

Akebia Therapeutics Signs Commercial Supply Contract ... - LinkedIn

Akebia Therapeutics Signs Commercial Supply Contract with Leading Dialysis Organization. Link: https://lnkd.in/e54jHiRP.

Akebia signs commercial supply contract with dialysis organization

Akebia (AKBA) Therapeutics announced that it has signed a multi-year commercial contract with one of the nation's leading providers of kidney care services.

Akebia Therapeutics Signs Commercial Supply Contract with a ...

Akebia Therapeutics, Inc. announced that it has signed a multi-year commercial contract with one of the nation's leading providers of kidney ...

Form 8-K for Akebia Therapeutics INC filed 10/22/2024

Akebia Therapeu cs Signs Commercial Supply Contract with Leading Dialysis Organiza on to Enable Access to Vafseo® (vadadustat) for Pa ents ...

Akebia Therapeutics Signs Commercial Supply Contract with ...

The contract enables physicians to prescribe Vafseo to patients on dialysis as deemed clinically appropriate. Akebia expects Vafseo will be ...

Akebia Therapeutics on X: "Akebia Therapeutics Signs Commercial ...

Akebia Therapeutics Signs Commercial Supply Contract with Leading Dialysis Organization. Link: https://t.co/tCCwnnFqL2.

Press Releases - Akebia Therapeutics

Akebia Therapeutics Signs Commercial Supply Contract with Leading Dialysis Organization to Enable Access to Vafseo® (vadadustat) for Patients on Dialysis.

Akebia Therapeutics Reports Third Quarter 2024 Financial Results ...

Butler , Chief Executive Officer of Akebia. "We expect to enter into contracts with additional dialysis providers to increase coverage over the ...

Akebia Therapeutics Signs Commercial Supply C - Futubull

AkebiaTherapeutics Signs Commercial Supply Contract With Leading Dialysis Organization to Enable Access to Vafseo® (Vadadustat) for Patients on Dialysis.

Akebia Therapeutics on X: "PRESS RELEASE: Akebia Therapeutics ...

PRESS RELEASE: Akebia Therapeutics and U.S. Renal Care Sign Commercial Supply Contract. Link here: https://t.co/l0mLQTzuIg.

Akebia Therapeutics Reports Inducement Grants Under Nasdaq ...

1, 2024 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney ...

Akebia Therapeutics Inc. (AKBA:US) | News & Upcoming Events

Akebia Therapeutics Signs Commercial Supply Contract with Leading Dialysis Organization to Enable Access to Vafseo® (vadadustat) for Patients on Dialysis.